ISSN: 1859 - 2872
Relationship between Peguero-Lo Presti index on ECG and clinical, paraclinical characteristics in patients with stage 5 chronic kidney disease on cyclical hemodilation
Main Article Content
Keywords
Abstract
Objective: To investigate the relationship between Peguero-Lo Presti index and clinical and paraclinical characteristics in patients with chronic kidney disease (CKD) stage 5 on dialysis. Subject and method: 75 patients were diagnosed with CKD according to KDIGO guideline-2012. Calculate the Peguero-Lo Presti index on the electrocardiogram. Result: The Peguero-Lo Presti index for diagnosing left ventricular hypertrophy on electrocardiogram compared with LMVI achieved a sensitivity of 73.3% and a specificity of 80%. The Peguero-Lo Presti index in the hypertensive group was greater than the non-hypertensive group (p<0.05), but there was no difference between the anemic group or the hypoalbumin group. There was a positive correlation between the Peguero-Lo Presti index and LVMI (r = 0.575 with p<0.05). Conclusion: Peguero-Lo Presti index is associated with left ventricular hypertrophy in patients with stage 5 CKD.
Article Details
References
2. Peguero JG, Lo Presti S Perez J et al (2017) Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. Journal of the American College of Cardiology 69(13): 1694-1703.
3. Rodrigues TS, Azraai M, Crosthwaite A et al (2019) The Peguero-Lo Presti criteria improve the sensitivity of the electrocardiogram to diagnose left ventricular hypertrophy in patients with end-stage kidney disease. Heart, Lung Circulation 28: 324.
4. Porthan K, Kenttä T, Niiranen TJ et al (2019) ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death. International Journal of Cardiology 276: 125-129.
5. Levin A, Stevens PE, Bilous RW et al (2013) Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international supplements 3(1): 1-150.
6. Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(3): 233-270. https://doi.org/10.1093/ehjci/jev014 PMID: 25712077.
7. Mark DB and Wong JB (2005) Decision-making in clinical medicine. Harrisons Principles Of Internal Medicine 16(1): 6.
8. Rodrigues TS, Azraai M, Crosthwaite A et al (2019) The Peguero-Lo Presti criteria improve the sensitivity of the electrocardiogram to diagnose left ventricular hypertrophy in patients with end-stage kidney disease. Heart, Lung Circulation 28: S324.
9. Braunisch MC, Gundel P, Werfel S et al (2022) Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients. Journal of Nephrology 35(1): 233-244.
10. Tiron C, Ramos R, Iglesies J et al (2021) The Peguero–Lo Presti ECG criteria improve diagnostic accuracy of left ventricular hypertrophy in hypertrophic cardiomyopathy patients. Journal of Cardiovascular Medicine 22(12): 946-947.
Article Sidebar
